arrow
J

Jean Doh

university of california—irvine
H指数:5
被引数:72

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7+3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia

Venetoclax联合克拉屈滨、伊达比星、阿糖胞苷(CLIA-VEN)在 newly diagnosed acute myeloid leukaemia 患者中可带来更高的缓解率,且未增加毒性,优于常规7+3化疗方案。

2025-11-010
OAAI
Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection

早期冠状病毒病2019感染的异基因干细胞移植患者免疫重建持续受损和生存结局恶化

2024-08-010
PRE